Baxter International (BAX.US) is scheduled to release its earnings report on February 12, prior to market open. The article also provides a brief overview of the company’s previous financial performance, noting a revenue of $2.835 billion and a net loss of $46 million for Q3 2025, and a revenue of $2.753 billion and a net loss of $512 million for Q4 2024. Investors are advised to stay tuned for the upcoming earnings report and the subsequent earnings call.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Baxter International (BAX.US) will release its earnings report before the market opens on February 12.
Baxter International (BAX.US) is scheduled to release its earnings report on February 12, prior to market open. The article also provides a brief overview of the company’s previous financial performance, noting a revenue of $2.835 billion and a net loss of $46 million for Q3 2025, and a revenue of $2.753 billion and a net loss of $512 million for Q4 2024. Investors are advised to stay tuned for the upcoming earnings report and the subsequent earnings call.